Search research articles
Contact Us
Filters
Showing results (221-230 of 241) with videos related to
Page
of 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2019
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study
Julien Edeline, Meher Benabdelghani, Aurélie Bertaut, et al.
Gastroenterology
|
June 19, 2012
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma
Raphaël Maréchal, Jean-Baptiste Bachet, John R Mackey, et al.
Iscience
|
April 20, 2026
Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities
Eduardo Chuluyan, Brice Chanez, Analia Meilerman, et al.
JCO Clinical Cancer Informatics
|
April 29, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer
Avelyn Wong, Taib A Bourega, Rémy Nicolle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2020
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
Eric Van Cutsem, Margaret A Tempero, Darren Sigal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2024
Resection of colorectal liver metastases with second-line aflibercept plus FOLFIRI: Results from the RESECTION prospective French cohort
David Tougeron, Frederic Bibeau, Benoist Chibaudel, et al.
Neuroendocrinology
|
July 11, 2018
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
Eric Raymond, Matthew H Kulke, Shukui Qin, et al.
Research Square
|
April 25, 2024
Activation of lysosomal iron triggers ferroptosis in cancer
Raphaël Rodriguez, Tatiana Cañeque, Leeroy Baron, et al.
Gastroenterology
|
November 22, 2017
Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Renato M Lupinacci, Anastasia Goloudina, Olivier Buhard, et al.
The New England Journal of Medicine
|
December 22, 2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Thierry Conroy, Pascal Hammel, Mohamed Hebbar, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 241) with videos related to
Sort By:
Page
of 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2019
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study
Julien Edeline, Meher Benabdelghani, Aurélie Bertaut, et al.
Gastroenterology
|
June 19, 2012
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma
Raphaël Maréchal, Jean-Baptiste Bachet, John R Mackey, et al.
Iscience
|
April 20, 2026
Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities
Eduardo Chuluyan, Brice Chanez, Analia Meilerman, et al.
JCO Clinical Cancer Informatics
|
April 29, 2026
Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer
Avelyn Wong, Taib A Bourega, Rémy Nicolle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2020
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
Eric Van Cutsem, Margaret A Tempero, Darren Sigal, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2024
Resection of colorectal liver metastases with second-line aflibercept plus FOLFIRI: Results from the RESECTION prospective French cohort
David Tougeron, Frederic Bibeau, Benoist Chibaudel, et al.
Neuroendocrinology
|
July 11, 2018
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours
Eric Raymond, Matthew H Kulke, Shukui Qin, et al.
Research Square
|
April 25, 2024
Activation of lysosomal iron triggers ferroptosis in cancer
Raphaël Rodriguez, Tatiana Cañeque, Leeroy Baron, et al.
Gastroenterology
|
November 22, 2017
Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Renato M Lupinacci, Anastasia Goloudina, Olivier Buhard, et al.
The New England Journal of Medicine
|
December 22, 2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Thierry Conroy, Pascal Hammel, Mohamed Hebbar, et al.
Page
of 25